Log In
BCIQ
Print this Print this
 

ARB-1598

  Manage Alerts
Collapse Summary General Information
Company Kuros Biosciences Ltd.
DescriptionVirus-like particle (VLP) containing an oligonucleotide agonist of toll-like receptor 9 (TLR9)
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) inhibitor
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat hepatitis B virus (HBV) infection
Regulatory Designation
PartnerArbutus Biopharma Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today